Last reviewed · How we verify

NCT03614598: DISPOSITIF LAR

Impact on Postoperative Pain of Three Single-use Adult Supraglottic Airway Devices in Short General Anesthetic Under Controlled Ventilation

Completed NA Last updated 17 November 2025
What this trial tests

NA trial testing Insertion of LMA-UNIQUE(TM) device in Pharyngolaryngeal Postoperative Pain in 546 participants. Completed in 6 September 2012.

Timeline
22 April 2009
Primary endpoint
5 September 2012
6 September 2012

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Nīmes
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment546
Start date22 April 2009
Primary completion5 September 2012
Estimated completion6 September 2012
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Nīmes

Who can join

18 and older, any sex, with Pharyngolaryngeal Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators hypothesize that incidence of pharyngolaryngeal postoperative pain caused by the I-gel and LMA-Suprême devices will be ≤ 5%

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pharyngolaryngeal Postoperative Pain

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de Nīmes trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03614598.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing